NO2575858T3 - - Google Patents

Info

Publication number
NO2575858T3
NO2575858T3 NO11790534A NO11790534A NO2575858T3 NO 2575858 T3 NO2575858 T3 NO 2575858T3 NO 11790534 A NO11790534 A NO 11790534A NO 11790534 A NO11790534 A NO 11790534A NO 2575858 T3 NO2575858 T3 NO 2575858T3
Authority
NO
Norway
Application number
NO11790534A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2575858T3 publication Critical patent/NO2575858T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO11790534A 2010-06-05 2011-06-06 NO2575858T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35186610P 2010-06-05 2010-06-05
PCT/US2011/039255 WO2011153525A2 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions

Publications (1)

Publication Number Publication Date
NO2575858T3 true NO2575858T3 (https=) 2018-05-19

Family

ID=45067339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO11790534A NO2575858T3 (https=) 2010-06-05 2011-06-06

Country Status (12)

Country Link
EP (2) EP3318269B1 (https=)
JP (1) JP5904560B2 (https=)
KR (1) KR20130132375A (https=)
CN (2) CN103140234B (https=)
AU (1) AU2011261196B2 (https=)
CA (1) CA2801579C (https=)
DK (1) DK2575858T3 (https=)
ES (1) ES2663096T3 (https=)
NO (1) NO2575858T3 (https=)
PL (1) PL2575858T3 (https=)
PT (1) PT2575858T (https=)
WO (1) WO2011153525A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
US20110301103A1 (en) 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment
WO2014145275A1 (en) 2013-03-15 2014-09-18 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
CN106170700A (zh) * 2014-01-20 2016-11-30 玛丽亚·阿黛尔·西尔维亚·丹尼杰奥派德4有限公司 用于狼疮肾炎的治疗性随访中的预测、诊断和监测的体外方法
EP4479079A4 (en) * 2022-02-14 2026-02-18 Sumant Singh Chugh METHODS OF TREATMENT OF A CYTOKINE STAMP DISEASE WITH A RECOMBINANT TYPE 4 MUTANT HUMAN ANGIOPOIETIN
CN114934021B (zh) * 2022-04-21 2023-08-08 复旦大学附属儿科医院 一种Angptl3敲除的鼠永生化足细胞系及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2379152A1 (en) * 1999-07-16 2001-01-25 Hyseq, Inc. Novel angiopoietin materials and methods
JP2005080508A (ja) * 2003-09-04 2005-03-31 Sankyo Co Ltd 脂質代謝改善剤の試験方法
CN1980686A (zh) * 2004-04-05 2007-06-13 安斯泰来制药有限公司 抗肥胖药
WO2006014678A2 (en) * 2004-07-20 2006-02-09 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein
AU2007227251A1 (en) * 2006-03-20 2007-09-27 Amgen Fremont, Inc. Antibodies directed to angiopoietin-like protein 4 and uses thereof
EP2155207A2 (en) * 2007-05-31 2010-02-24 Government Of The United States Of America As Represented by Secretary of the Dep. of Health and Human Services National Institute of Health N-acetyl mannosamine as a therapeutic agent

Also Published As

Publication number Publication date
CA2801579A1 (en) 2011-12-08
EP2575858B1 (en) 2017-12-20
PL2575858T3 (pl) 2018-08-31
ES2663096T3 (es) 2018-04-11
AU2011261196A1 (en) 2013-01-10
PT2575858T (pt) 2018-03-22
EP2575858A2 (en) 2013-04-10
AU2011261196B2 (en) 2015-05-21
JP2013528625A (ja) 2013-07-11
DK2575858T3 (en) 2018-03-12
WO2011153525A2 (en) 2011-12-08
KR20130132375A (ko) 2013-12-04
CN107412729A (zh) 2017-12-01
JP5904560B2 (ja) 2016-04-13
HK1252916A1 (en) 2019-06-06
CN103140234A (zh) 2013-06-05
EP3318269A1 (en) 2018-05-09
WO2011153525A9 (en) 2012-04-19
CN103140234B (zh) 2016-12-21
CA2801579C (en) 2021-12-14
EP3318269B1 (en) 2024-03-13
EP3318269C0 (en) 2024-03-13
EP2575858A4 (en) 2014-01-01

Similar Documents

Publication Publication Date Title
BR112013008959A2 (https=)
BR112012030039A2 (https=)
BR112012019354A2 (https=)
BR112012028408A2 (https=)
BR112012029986A2 (https=)
BR112012027808A2 (https=)
BR112012024897A2 (https=)
BR112012026492A2 (https=)
BR112012031500A2 (https=)
BR112012025307A2 (https=)
BR112012017960A2 (https=)
BR112012002126A2 (https=)
BR112012026946A2 (https=)
BR112012025482A2 (https=)
BR112013006400A2 (https=)
BR112012031826A2 (https=)
BR112012023249A2 (https=)
BR112012025577A2 (https=)
BR112012028186A2 (https=)
BR112012016456A2 (https=)
BR112012018256A2 (https=)
BR112012027015A2 (https=)
BR112012025308A2 (https=)
BR112012027945A2 (https=)
BR112013010949A2 (https=)